From Alphastreet - Earnings Decoded. Market Intelligence Delivered · AlphaStreet Newsdesk · · 50s
SBC Medical Group Holdings Beats Q3 2026 Earnings
SBC Medical Group Holdings beats Q3 2026 profit estimates by 25.0% with strong revenue growth.
In brief
SBC Medical Group Holdings beats Q3 2026 profit estimates by 25.0% with strong revenue growth. SBC Medical Group Holdings reported Q3 2026 earnings of $0.15 per share, exceeding analyst forecasts by 25.0%. Originally reported by Alphastreet - Earnings Decoded. Market Intelligence Delivered.
Solid Beat
SBC Medical Group Holdings delivered Q3 2026 earnings of $0.15 per share, surpassing analysts' $0.12 forecast by 25.0%.
Revenue-Driven Growth
Revenue of $58.6M exceeded Wall Street's $48.9M forecast, showing 35.0% year-over-year growth from Q3 2025.
“3rd quarter revenue was 59 million, up 35 percent year on year”
Operational Footprint
The company operates 293 clinic locations with 7.06M patient visits, indicating steady utilization across the network.
“For the first 9 months of the year, same clinic revenue reached 836 million, up 7 percent year on year”
Analyst Positioning
Wall Street consensus shows 4 buy ratings and 0 sell recommendations, reflecting positive sentiment for SBC's growth trajectory.
Stock Reaction
Shares rose 1.9% to $5.34 following the results, a relatively muted response given the degree of the beat.
What matters most
SBC Medical Group Holdings reported Q3 2026 earnings of $0.15 per share, exceeding analyst forecasts by 25.0%.
